Satellite sessions

Refreshments will be available before the start of each session.

Monday 7th April

10.30-12.30
Controversies in the diagnosis and management of hypogonadism - Andrology Special Interest Group Satellite
  Sponsored by:
  Bayer Schering Pharma Bayer Schering Pharma
  ProStrakan ProStrakan
  Queens Suite 1
  Chair: H Jones (Sheffield)
10.30  Hypogonadism and Diabetes
  H Jones (Sheffield)
   
10.50 Aging, Frailty and Testosterone
  F Wu (Manchester)
   
11.10 Difficulties in the Diagnosis of Hypogonadism
  S Arver (Stockholm, Sweden)
   
11.30   Testosterone and Prostate Safety
  M Feneley (London)
   
11.50    Discussion
   
  This session has been accredited for 2 CPD points

 

10.30-12.30
Osteoporosis - Bone and Mineral Special Interest Group Satellite
  In association with the National Osteoporosis Society
  Sponsored by:
  Novartis  Novartis Ireland
  Roche GlaxoSmithKline | Roche
  Queens Suite 2
10.30   Reception
   
11.00    Chairman’s introduction
  Osteoporosis – the silent epidemic?
  J Wass (Oxford) & R Eastell (Sheffield)
   
11.10 NICE ways to manage osteoporosis
  P Selby (Manchester)
   
11.30 ‘But doctor I can’t take generic alendronic acid!’
  R Eastell (Sheffield)
   
11.50    ‘But doctor no guidelines apply to my situation!’
  S Orme (Leeds)
   
12.10 So you want to set up an osteoporosis service?
  A McLellan (Glasgow)
   
  This session has been accredited for 2 CPD points

Wednesday 9th April

18.45-20.45
Advances in PCOS in the last 12 months - Polycystic Ovary Syndrome and Metabolic Syndrome Special Interest Group Satellite
  Sponsored by:
  AlmirallAlmirall
  Main auditorium
  Chairs: S Atkin (Hull) & H Randeva (Warwick)
18.45 An update and highlights of the basic science advances of PCOS
  H Randvra (Warwick)
   
 19.15 An update and highlights of the reproductive aspects of PCOS
  A Balen (Leeds)
   
19.45 An update and highlights of the cosmetic aspects of PCOS
  A Layton (Harrogate)
   
20.15  Discussion
   
  This session has been accredited for 2 CPD points

 

18.45-20.45
Neuroendocrine Tumours Satellite
  Sponsored by:
  Novartis IrelandNovartis Ireland
  Queens Suite 1
  Chairs: D O’Shea (Dublin, Ireland)
18.45 Clinical case discussions and current clinical trials for neuroendocrine tumours
  K Meeran (London) & J Newell-Price (Sheffield)
   
19.15 Diagnostic and treatment algorithm for neuroendocrine tumours
  D O’Shea (Dublin, Ireland)
   
19.45  Mechanisms underlying neuroendocrine tumourigenesis and development of models
  R Thakker (Oxford)
   
20.15   Tumour targeted radioactive treatment of neuroendocrine tumours
  D Kwekkeboom (Rotterdam,The Netherlands)
   
  This session has been accredited for 2 CPD points